Classification of vitiligo: A challenging endeavor

Dermatologic Therapy

Volumn 25, Issue SUPPL.1, 2012, Pages

  Hercogová, Jana ^a   Schwartz, Robert A ^b   Lotti, Torello M ^c,d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c Department of Dermatology and Venereology University of Rome G Marconi ^*  (Italy)

^d Vitiligo Research Foundation   (United States)

Author keywords

Classification; Treatment; Vitiligo

Indexed keywords

HOMOVANILLIC ACID; HYDROGEN PEROXIDE; MELANIN; NEUROPEPTIDE Y; SAPROPTERIN; VANILMANDELIC ACID;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CELL SURVIVAL; COMORBIDITY; DESMOSOME; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; FOLLOW UP; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETICS; HAPLOTYPE; HLA SYSTEM; HUMAN; KERATINOCYTE; LEUKODERMA; MELANOCYTE; MELANOGENESIS; OXIDATIVE STRESS; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO; CLASSIFICATION; SEVERITY OF ILLNESS INDEX;

HUMANS; SEVERITY OF ILLNESS INDEX; VITILIGO;

EID: 84875907946     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12010     Document Type: Article

References (31)

1. Lotti T, Hercogová J, eds. Vitiligo - problems and solutions. New York, NY: Marcel Dekker Inc., 2004: 18-66.
2. Shajil EM, Chatterjee S, Agrawal D, Bagchi T, Begum R. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes. Indian J Exp Biol 2006: 44: 546-539.
3. Nordlund JJ, Lerner AB. Vitiligo. It is important. Arch Dermatol 1982: 118: 5-8.
4. Onunu AN, Kubeyinje EP. Vitiligo in the Nigerian African: a study on 351 patients in Benin City in Nigeria. Int J Dermatol 2003: 42: 800-802.
5. Hann SK, Lee HJ. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 1996: 35: 671-674.
6. Barona MI, Arrunategui A, Falabella R, Alzate A. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol 1995: 33: 621-625.
7. Alkhateeb A, Fain PR, Thody A, Bennet DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003: 16: 208-214.
8. Majumder PA. Genetics and prevalence of vitiligo vulgaris. In: Hann SK, Nordlund JJ, eds. Vitiligo: a monograph on the basic and clinical science. Oxford: Blackwell Science Ltd, 2000: 18-20.
9. Sun X, Xu A, Wei X, et al. Genetic epidemiology of vitiligo: a study of 815 probands and their families from South China. Int J Dermatol 2006: 45: 1176-1181.
10. Spritz RA. The genetics of generalized vitiligo. Curr Dir Autoimmun 2008: 10: 244-257.
11. Birlea SA, Laberge GS, Procopciuc LM, Fain PR, Spritz RA. CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data. Pigment Cell Melanoma Res 2009: 22: 230-234.
12. Jin Y, Malloux CM, Gowan K, et al. NALP1 in vitiligoassociated multiple autoimmune disease. N Engl J Med 2007: 356: 1216-1225.
13. Fain PR, Gowan K, LaBerge GS, et al. A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 2003: 72: 1560-1564.
14. Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosome 7 (AIS2) and 8 (AIS3) confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 2004: 74: 188-191.
15. Bystryn JC. Serum antibodies in vitiligo patients. Clin Dermatol 1989: 7: 136-145.
16. Cu J, Arita Y, Bystryn JC. Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol 1993: 100: 812-815.
17. Norris DA, Kissinger RM, Naughton GM, Bystryn JC. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol 1988: 90: 783-789.
18. Al'Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol 1994: 131: 160-165.
19. Morrone A, Picardo M, de Luca C, Terminali O, Passi S, Ippolito F. Catecholamines and vitiligo. Pigment Cell Res 1992: 5: 65-69.
20. Schallreuter KU, Wood JM, Pittelkow MR, et al. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 1994: 263: 1444-1446.
21. Schallreuter KU, Buttner G, Pittelkow MR, Wood JM, Swanson NN, Korner C. Cytotoxicity of 6-biopterin to human melanocytes. Biochem Biophys Res Commun 1994: 204: 43-48.
22. Schallreuter KU,Moore J,Wood JM, et al. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 1999: 4: 91-96.
23. Schallreuter KU,Wood JM, Ziegler I, et al. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim Biophys Acta 1994: 1226: 181-192.
24. Beazley WD, Gaze D, Panske A, Panzig E, Schallreuter KU. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 1999: 141: 301-303.
25. Badri AM, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, Goudie RB. An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol 1993: 170: 149-155.
26. Gauthier Y, Cario-AndreM, Lepreux S, Pain C, Taieb A.Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br J Dermatol 2003: 148: 95-101.
27. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocytes adhesion. Br J Dermatol 1997: 137: 171-178.
28. Kitamura R, Tsukamoto K, Harada K, et al. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interaction and the downstream effector, MITF-M. J Pathol 2004: 202: 463-475.
29. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 2011: 65: 473-491.
30. Hann SK, KimYS, Yoo JH, Chun YS. Clinical and histopathologic characteristics of trichrome vitiligo. J AmAcadDermatol 2004: 42: 589-596.
31. Ortonne JP. Vitiligo and other disorders of hypopigmentation. In: Bolognia J, Jorizzo J, Rapini R, eds. Dermatology. Philadelphia: Mosby Elsevier, 2008: 928.